Answers are grounded in this paper and cite their sources.
To the best of our knowledge, BMVision is the first clinically validated commercial artificial intelligence tool for kidney cancer detection and characterization. By improving diagnostic accuracy and reporting efficiency, it has the potential to enhance patient care and help radiologists meet the growing demand for high-quality cancer diagnostics.
No takes yet. Share an insight, caveat, or question.
Iljin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: